|
Droncit Feline 23 mg (per tablet)
View other items in the same category as Droncit Feline 23 mg (per tablet) Product UsesDroncit Feline Cestocide Tablets are indicated for the removal of the following feline tapeworms: Dipylidium caninum and Taenia taeniaeformis. Product ContainsEach tablet contains 23 mg praziquantel. Dosage and AdministrationDroncit Feline Cestocide Tablets may be administered directly into the mouth or crumbled and mixed with the feed. The recommended dosage of praziquantel varies according to body weight. Smaller animals require a relatively larger dosage because of their higher metabolic rate. The optimum dose for each individual animal will be achieved by utilizing the following dosage schedule: cats and kittens 4lbs and under: 1/2 a tablet; cats 5-11lbs: 1 tablet; cats over 11lbs:1 1/2 tablets.The recommended dosage of praziquantel is not affected by the presence or absence of food in the gastrointestinal tract. It is not necessary to fast animals prior to administration of Droncit For those animals maintained on premises where reinfections are likely to occur, steps should be taken to prevent reinfection; otherwise, retreatment may be necessary. In flea tapeworm (Dipylidium caninum) infections, reinfection is almost certain to occur if fleas are not removed from the animal and its environment. Warnings, Side Effects and Drug InteractionsThere are no known contraindications to the use of praziquantel in cats except that the product is not intended for use in kittens less than 6 weeks of age. The product has a high safety margin. Symptoms of overdosage may include vomition, salivation, diarrhea and depression. Droncit has been tested in breeding and pregnant cats and no adverse effects of treatment were noted. StorageStore at room temperature. ManufacturerBayer HealthCare LLC, Animal Health Division Federal law restricts this drug to use by or on the order of a licensed veterinarian.
|